BG Medicine (OTCMKTS:BGMD) Shares Pass Above 200-Day Moving Average – What’s Next?

Shares of BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. BG Medicine shares last traded at $0.00, with a volume of 0 shares trading hands.

BG Medicine Trading Down 100.0%

Get BG Medicine alerts:

BG Medicine Company Profile

(Get Free Report)

BG Medicine, Inc, headquartered in Waltham, Massachusetts, is a clinical diagnostics company specializing in proprietary biomarker assays for the diagnosis and management of cardiovascular and renal diseases. The company’s flagship product is a B-type natriuretic peptide (BNP) test, offered both as a laboratory-developed test in its CLIA-certified facility and as reagent kits compatible with major immunoassay analyzers. This test aids clinicians in assessing heart failure severity and guiding patient treatment decisions.

Founded in the early 2000s, BG Medicine has established partnerships with hospital and reference laboratories across North America and select international markets.

Further Reading

• Five stocks we like better than BG Medicine
• 3 Unexpected ETFs Crushing the Market This Summer
• Is Best Buy the AI Winner Hiding in the Electronics Aisle?
• Applied Materials Beat Everything but Wall Street’s Expectations for Margins
• Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone

Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.